178 related articles for article (PubMed ID: 27716059)
1. IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients.
Sadeghi M; Lahdou I; Opelz G; Mehrabi A; Zeier M; Schnitzler P; Daniel V
BMC Immunol; 2016 Oct; 17(1):35. PubMed ID: 27716059
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses.
Toupance O; Bouedjoro-Camus MC; Carquin J; Novella JL; Lavaud S; Wynckel A; Jolly D; Chanard J
Transpl Int; 2000; 13(6):413-9. PubMed ID: 11140239
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of Cytomegalovirus-Specific Cytokine Production after Modulation of the Costimulation in Kidney Transplant Patients.
Dornieden T; Wilde B; Korth J; Werner K; Horn PA; Witzke O; Lindemann M
J Immunol Res; 2019; 2019():3926175. PubMed ID: 30931336
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor.
Fietze E; Prösch S; Reinke P; Stein J; Döcke WD; Staffa G; Löning S; Devaux S; Emmrich F; von Baehr R
Transplantation; 1994 Sep; 58(6):675-80. PubMed ID: 7940686
[TBL] [Abstract][Full Text] [Related]
6. Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients.
Rittà M; Costa C; Sidoti F; Ballocco C; Ranghino A; Messina M; Biancone L; Cavallo R
New Microbiol; 2015 Jul; 38(3):329-35. PubMed ID: 26147141
[TBL] [Abstract][Full Text] [Related]
7. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
Merlino C
G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.
Vu D; Shah T; Ansari J; Sakharkar P; Yasir Q; Naraghi R; Hutchinson I; Min D
Transpl Infect Dis; 2014 Oct; 16(5):724-32. PubMed ID: 25208755
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.
Frantzeskaki FG; Karampi ES; Kottaridi C; Alepaki M; Routsi C; Tzanela M; Vassiliadi DA; Douka E; Tsaousi S; Gennimata V; Ilias I; Nikitas N; Armaganidis A; Karakitsos P; Papaevangelou V; Dimopoulou I
J Crit Care; 2015 Apr; 30(2):276-81. PubMed ID: 25457114
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
[TBL] [Abstract][Full Text] [Related]
11. Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients.
Iglesias-Escudero M; Moro-García MA; Marcos-Fernández R; García-Torre A; Álvarez-Argüelles ME; Suárez-Fernández ML; Martínez-Camblor P; Rodríguez M; Alonso-Arias R
PLoS One; 2018; 13(4):e0194789. PubMed ID: 29641536
[TBL] [Abstract][Full Text] [Related]
12. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
13. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection.
Christmas SE; Halliday D; Lawton N; Wang H; Abdalla I; Masters J; Hassan RL; Hart IJ; Khan N; Smith J; Hammad A; Bakran A
Transpl Immunol; 2009 Dec; 22(1-2):99-104. PubMed ID: 19635559
[TBL] [Abstract][Full Text] [Related]
15. Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients.
Pietersma FL; van Dorp S; Minnema MC; Kuball J; Meijer E; Schuurman R; van Baarle D
Clin Infect Dis; 2011 Apr; 52(7):e144-8. PubMed ID: 21427386
[TBL] [Abstract][Full Text] [Related]
16. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
17. Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation.
de Rham C; Hadaya K; Bandelier C; Ferrari-Lacraz S; Villard J
Transpl Immunol; 2014 Sep; 31(3):157-64. PubMed ID: 25158213
[TBL] [Abstract][Full Text] [Related]
18. Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China.
Jin ZK; Xu CX; Tian PX; Xue WJ; Ding XM; Zheng J; Ding CG; Ge GQ; Mao TC; Lin Y
Transpl Immunol; 2012 Oct; 27(2-3):69-74. PubMed ID: 22750489
[TBL] [Abstract][Full Text] [Related]
19. Characterization of antibody response to human cytomegalovirus in Indian renal transplant patients.
Finny GJ; Rao M; Mach M; Juneja R; Thomas PP; Jacob CK; Manayani DJ; Abraham P; Abraham M; Sridharan G
Indian J Med Res; 2001 Jun; 113():221-7. PubMed ID: 11816956
[TBL] [Abstract][Full Text] [Related]
20. Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.
van de Groep K; Nierkens S; Cremer OL; Peelen LM; Klein Klouwenberg PMC; Schultz MJ; Hack CE; van der Poll T; Bonten MJM; Ong DSY;
Crit Care; 2018 Dec; 22(1):348. PubMed ID: 30563551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
